Skip to content

VisionCare’s implantable telescope secures reimbursement

VisionCare Ophthalmic Technologies, Inc., a specialty medical device company based in Saratoga California, have announced that the Centres for Medicare and Medicaid Services (CMS), a federal agency within the US Dept. of Health & Human Services (DHHS), have granted transitional pass-through payment status and a clinician billing code for the company’s Implantable Miniature Telescope (IMT). The IMT prosthetic device is the first FDA-approved implantable medical device for improving vision in patients with advanced irreversible age-related macular degeneration (AMD) and the grant for payment status and billing code now enables outpatient facilities to obtain reimbursement for the IMT for covered procedures.